Cabanlit, Ivan Jay P.
HRN: 23-94-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/18/2023
10/25/2023
IV
440mg
Q6
PCAP C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes